Drug details

Aurovela (norethindrone acetate and ethinyl estradiol tablets)

type of

Aurovela 1.5/30 (norethindrone acetate and ethinyl estradiol tablets) is a combination of female hormones indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception.

This drug may have the following side effects:

• nausea,
• vomiting,
• depression,
• missed menstrual periods, 
• abdominal cramps,
• bloating,
• breakthrough bleeding,
• cholestatic jaundice,
• migraine,
• changes in weight,
• rash (allergic),
• temporary infertility after discontinuation of treatment,
• spotting, changes in menstrual flow,
• fluid retention (edema),
• skin discoloration which may persist breast changes (tenderness, enlargement, nipple discharge),
• diminished milk production in lactating women when given immediately postpartum,
• reduced tolerance to carbohydrates,
• vaginal yeast infection, and
• problems with contact lenses

The following drugs are related to Aurovela, either as a replacement or used together:

• Depo-Provera (medroxyprogesterone)
• Implanon (etonogestrel implant)
• ParaGard (intrauterine copper contraceptive)
• Norplant (levonorgestrel implants (unavailable in us))
• Mirena (levonorgestrel-releasing intrauterine system)
• Skyla (levonorgestrel-releasing intrauterine system)
• Liletta (levonorgestrel-releasing intrauterine system)